The Strategies Behind Galderma and Benev

In this episode of Medical Spa Insider, Alex Thiersch facilitates high-level discussions with two industry executives shaping the trajectory of the aesthetic market. Silvina Nordenstahl, President of the US organization at Galderma, discusses the operational imperatives of scaling a global aesthetic enterprise and the central role of patient-centricity in long-term strategy. Following this, Ethan Min, CEO of Benev, outlines the strategic shift required to successfully introduce global innovations into the US market, focusing on the critical nature of regulatory compliance and the future of regenerative aesthetic technologies. This conversation provides a strategic perspective on navigating the current aesthetic landscape, emphasizing organizational culture, market validation, and the pursuit of long-term sustainable growth. Discussion points include: 03:00: Shifting to patient-centric innovation and addressing specific patient needs, such as weight loss and menopause support 06:15: Scaling and pursuing innovation without sacrificing safety and quality 08:20: Defining a high-performance culture and building a team to match 17:10: Benev's shift from traditional manufacturing model to a distribution platform 22:45: Using strict regulations to encourage higher quality standards  30:30: Regenerative medicine and collagen technologies emerging from the Korean market